期刊文献+

恩替卡韦治疗失代偿期乙型肝炎肝硬化疗效观察 被引量:2

下载PDF
导出
出处 《肝脏》 2009年第4期350-350,共1页 Chinese Hepatology
  • 相关文献

参考文献2

二级参考文献31

  • 1[2]Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol , 1993,4: 273-283.
  • 2[3]Liaw YF, Leung N, Guan R, et al. Asian-Pacific consensus state ment on the management of chronic hepatitis B: An update for the Asian-Pacific consensus working parties on Hepatitis B. Gastroenterol Hepatol, 2003, 18: 239-245.
  • 3[4]Lai CL, Chien RN, Leung NWY,et al. Aone-year trial of lamivudine for chronic hepatitis B. N Eng1 J Med, 1998,339:61-68.
  • 4[8]The EASL Jury. EASL international consensus conference on hepatitis B. J Hepatol, 2003, 38: 523-540.
  • 5[9]Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology , 2001,34:1225-1241.
  • 6[10]Li LL, Chun TW,Yin ML, et al. Prophylactic lamivudine prevents hepatitis B reactivation and mortality in patients receiving immunosup pression and chemotherapy. Hepatology , 2000,32:1183-1190.
  • 7[11]Lok AS, McMahon BJ. Chronic hepatitis B. https://www, aasld. org/eweb.
  • 8[12]Liaw YF, Sung JJY, Chow WC, et al. Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B: a prospective double-blined placebo-controlled clinical trial. Hepatology, 2003,38 (suppl 1 ): 262A.
  • 9[13]De Jongh FE, Janssen HLA, De Man RA, et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology , 1992,103:1630-1635.
  • 10[14]Fontana RJ. Mangement of patients with decompensated HBV cirrhosis. Semin Liver Dis, 2003 ,23:89-100

共引文献14023

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部